Fabry Patient Law Suit and Request to NIH for March-in Petition Rehearing

Patently BIOtech

An article out of the Genomics Law Report discussing the recent law suit citing violations of the Bayh Dole Act.

A second article from Patent Docs discusses the request for rehearing of the patients petition to the NIH for march-in.

Patently BIOtech  |  Email This Post  |  Printer Friendly
Tags: , , , , , , ,

One Response to Fabry Patient Law Suit and Request to NIH for March-in Petition Rehearing

  1. This case could have significant future repercussions for patent litigation, in regard to Bayh-Dole — which could put Genzyme under legal obligation to provide a secondary manufacturing source. I hope you will keep us updated on its progress.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>